Global Alzheimer's Disease Drug Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

Publisher Name :
Date: 19-Jul-2021
No. of pages: 118
Inquire Before Buying

Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.

The major players in global Alzheimer's Disease Drug market include Allergan, Eisai, Novartis, Daiichi Sankyo, Merz Pharma, Pfizer, Johnson & Johnson, Lundbeck, etc. The top 3 players hold over 60% of global shares. Europe and North America are main markets, they occupy over 70% of the global market. Memantine and Donepezil are the main types, with a share about 70%. Early to Moderate Stages is the key application, which covers over 55% shares.

Market Analysis and Insights: Global Alzheimer's Disease Drug Market

In 2020, the global Alzheimer's Disease Drug market size was US$ 3539 million and it is expected to reach US$ 3956.1 million by the end of 2027, with a CAGR of 1.5% during 2021-2027.

Global Alzheimer's Disease Drug Scope and Market Size

Alzheimer's Disease Drug market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Alzheimer's Disease Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2016-2027.

Segment by Type, the Alzheimer's Disease Drug market is segmented into

- Donepezil

- Memantine

- Rivastigmine

- Others

Segment by Application, the Alzheimer's Disease Drug market is segmented into

- Early to Moderate Stages

- Moderate to Severe Stages

Regional and Country-level Analysis:

- North America

- - United States

- - Canada

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Southeast Asia

- - Australia

- - Rest of Asia-Pacific

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Competitive Landscape and Alzheimer's Disease Drug Market Share Analysis

Alzheimer's Disease Drug market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2016-2021. Details included are company description, major business, Alzheimer's Disease Drug product introduction, recent developments, Alzheimer's Disease Drug sales by region, type, application and by sales channel.

The major companies include:

- Allergan

- Eisai

- Novartis

- Daiichi Sankyo

- Merz Pharma

- Pfizer

- Johnson & Johnson

- Lundbeck

Global Alzheimer's Disease Drug Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

Table of Contents
1 Study Coverage
1.1 Alzheimer's Disease Drug Product Introduction
1.2 Market by Type
1.2.1 Global Alzheimer's Disease Drug Market Size Growth Rate by Type
1.2.2 Donepezil
1.2.3 Memantine
1.2.4 Rivastigmine
1.2.5 Others
1.3 Market by Application
1.3.1 Global Alzheimer's Disease Drug Market Size Growth Rate by Application
1.3.2 Early to Moderate Stages
1.3.3 Moderate to Severe Stages
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Alzheimer's Disease Drug Market Size Estimates and Forecasts
2.1.1 Global Alzheimer's Disease Drug Revenue 2016-2027
2.1.2 Global Alzheimer's Disease Drug Sales 2016-2027
2.2 Alzheimer's Disease Drug Market Size by Region: 2021 Versus 2027
2.3 Alzheimer's Disease Drug Sales by Region (2016-2027)
2.3.1 Global Alzheimer's Disease Drug Sales by Region: 2016-2021
2.3.2 Global Alzheimer's Disease Drug Sales Forecast by Region (2022-2027)
2.3.3 Global Alzheimer's Disease Drug Sales Market Share by Region (2016-2027)
2.4 Alzheimer's Disease Drug Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Alzheimer's Disease Drug Revenue by Region: 2016-2021
2.4.2 Global Alzheimer's Disease Drug Revenue Forecast by Region (2022-2027)
2.4.3 Global Alzheimer's Disease Drug Revenue Market Share by Region (2016-2027)
3 Global Alzheimer's Disease Drug by Manufacturers
3.1 Global Top Alzheimer's Disease Drug Manufacturers by Sales
3.1.1 Global Alzheimer's Disease Drug Sales by Manufacturer (2016-2021)
3.1.2 Global Alzheimer's Disease Drug Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Alzheimer's Disease Drug Manufacturers by Revenue
3.2.1 Global Alzheimer's Disease Drug Revenue by Manufacturer (2016-2021)
3.2.2 Global Alzheimer's Disease Drug Revenue Share by Manufacturer (2016-2021)
3.3 Global Alzheimer's Disease Drug Price by Manufacturer (2016-2021)
3.4 Competitive Landscape
3.4.1 Key Alzheimer's Disease Drug Manufacturers Covered: Ranking by Revenue
3.4.2 Global Alzheimer's Disease Drug Market Concentration Ratio (CR5 and HHI) & (2016-2021)
3.4.3 Global Alzheimer's Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Alzheimer's Disease Drug Manufacturing Base Distribution, Product Type
3.5.1 Alzheimer's Disease Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Alzheimer's Disease Drug Product Type
3.5.3 Date of International Manufacturers Enter into Alzheimer's Disease Drug Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Allergan
4.1.1 Allergan Corporation Information
4.1.2 Allergan Description, Business Overview
4.1.3 Allergan Alzheimer's Disease Drug Products Offered
4.1.4 Allergan Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2016-2021)
4.1.5 Allergan Alzheimer's Disease Drug Revenue by Product
4.1.6 Allergan Alzheimer's Disease Drug Revenue by Application
4.1.7 Allergan Alzheimer's Disease Drug Revenue by Geographic Area
4.1.8 Allergan Alzheimer's Disease Drug Revenue by Sales Channel
4.1.9 Allergan Recent Development
4.2 Eisai
4.2.1 Eisai Corporation Information
4.2.2 Eisai Description, Business Overview
4.2.3 Eisai Alzheimer's Disease Drug Products Offered
4.2.4 Eisai Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2016-2021)
4.2.5 Eisai Alzheimer's Disease Drug Revenue by Product
4.2.6 Eisai Alzheimer's Disease Drug Revenue by Application
4.2.7 Eisai Alzheimer's Disease Drug Revenue by Geographic Area
4.2.8 Eisai Alzheimer's Disease Drug Revenue by Sales Channel
4.2.9 Eisai Recent Development
4.3 Novartis
4.3.1 Novartis Corporation Information
4.3.2 Novartis Description, Business Overview
4.3.3 Novartis Alzheimer's Disease Drug Products Offered
4.3.4 Novartis Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2016-2021)
4.3.5 Novartis Alzheimer's Disease Drug Revenue by Product
4.3.6 Novartis Alzheimer's Disease Drug Revenue by Application
4.3.7 Novartis Alzheimer's Disease Drug Revenue by Geographic Area
4.3.8 Novartis Alzheimer's Disease Drug Revenue by Sales Channel
4.3.9 Novartis Recent Development
4.4 Daiichi Sankyo
4.4.1 Daiichi Sankyo Corporation Information
4.4.2 Daiichi Sankyo Description, Business Overview
4.4.3 Daiichi Sankyo Alzheimer's Disease Drug Products Offered
4.4.4 Daiichi Sankyo Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2016-2021)
4.4.5 Daiichi Sankyo Alzheimer's Disease Drug Revenue by Product
4.4.6 Daiichi Sankyo Alzheimer's Disease Drug Revenue by Application
4.4.7 Daiichi Sankyo Alzheimer's Disease Drug Revenue by Geographic Area
4.4.8 Daiichi Sankyo Alzheimer's Disease Drug Revenue by Sales Channel
4.4.9 Daiichi Sankyo Recent Development
4.5 Merz Pharma
4.5.1 Merz Pharma Corporation Information
4.5.2 Merz Pharma Description, Business Overview
4.5.3 Merz Pharma Alzheimer's Disease Drug Products Offered
4.5.4 Merz Pharma Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2016-2021)
4.5.5 Merz Pharma Alzheimer's Disease Drug Revenue by Product
4.5.6 Merz Pharma Alzheimer's Disease Drug Revenue by Application
4.5.7 Merz Pharma Alzheimer's Disease Drug Revenue by Geographic Area
4.5.8 Merz Pharma Alzheimer's Disease Drug Revenue by Sales Channel
4.5.9 Merz Pharma Recent Development
4.6 Pfizer
4.6.1 Pfizer Corporation Information
4.6.2 Pfizer Description, Business Overview
4.6.3 Pfizer Alzheimer's Disease Drug Products Offered
4.6.4 Pfizer Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2016-2021)
4.6.5 Pfizer Alzheimer's Disease Drug Revenue by Product
4.6.6 Pfizer Alzheimer's Disease Drug Revenue by Application
4.6.7 Pfizer Alzheimer's Disease Drug Revenue by Geographic Area
4.6.8 Pfizer Recent Development
4.7 Johnson & Johnson
4.7.1 Johnson & Johnson Corporation Information
4.7.2 Johnson & Johnson Description, Business Overview
4.7.3 Johnson & Johnson Alzheimer's Disease Drug Products Offered
4.7.4 Johnson & Johnson Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2016-2021)
4.7.5 Johnson & Johnson Alzheimer's Disease Drug Revenue by Product
4.7.6 Johnson & Johnson Alzheimer's Disease Drug Revenue by Application
4.7.7 Johnson & Johnson Alzheimer's Disease Drug Revenue by Geographic Area
4.7.8 Johnson & Johnson Recent Development
4.8 Lundbeck
4.8.1 Lundbeck Corporation Information
4.8.2 Lundbeck Description, Business Overview
4.8.3 Lundbeck Alzheimer's Disease Drug Products Offered
4.8.4 Lundbeck Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2016-2021)
4.8.5 Lundbeck Alzheimer's Disease Drug Revenue by Product
4.8.6 Lundbeck Alzheimer's Disease Drug Revenue by Application
4.8.7 Lundbeck Alzheimer's Disease Drug Revenue by Geographic Area
4.8.8 Lundbeck Recent Development
5 Breakdown Data by Type
5.1 Global Alzheimer's Disease Drug Sales by Type (2016-2027)
5.1.1 Global Alzheimer's Disease Drug Sales by Type (2016-2021)
5.1.2 Global Alzheimer's Disease Drug Sales Forecast by Type (2022-2027)
5.1.3 Global Alzheimer's Disease Drug Sales Market Share by Type (2016-2027)
5.2 Global Alzheimer's Disease Drug Revenue Forecast by Type (2016-2027)
5.2.1 Global Alzheimer's Disease Drug Revenue by Type (2016-2021)
5.2.2 Global Alzheimer's Disease Drug Revenue Forecast by Type (2022-2027)
5.2.3 Global Alzheimer's Disease Drug Revenue Market Share by Type (2016-2027)
5.3 Alzheimer's Disease Drug Average Selling Price (ASP) by Type (2016-2027)
6 Breakdown Data by Application
6.1 Global Alzheimer's Disease Drug Sales by Application (2016-2027)
6.1.1 Global Alzheimer's Disease Drug Sales by Application (2016-2021)
6.1.2 Global Alzheimer's Disease Drug Sales Forecast by Application (2022-2027)
6.1.3 Global Alzheimer's Disease Drug Sales Market Share by Application (2016-2027)
6.2 Global Alzheimer's Disease Drug Revenue Forecast by Application (2016-2027)
6.2.1 Global Alzheimer's Disease Drug Revenue by Application (2016-2021)
6.2.2 Global Alzheimer's Disease Drug Revenue Forecast by Application (2022-2027)
6.2.3 Global Alzheimer's Disease Drug Revenue Market Share by Application (2016-2027)
6.3 Alzheimer's Disease Drug Average Selling Price (ASP) by Application (2016-2027)
7 North America
7.1 North America Alzheimer's Disease Drug Market Size YoY Growth 2016-2027
7.2 North America Alzheimer's Disease Drug Market Facts & Figures by Country
7.2.1 North America Alzheimer's Disease Drug Sales by Country (2016-2027)
7.2.2 North America Alzheimer's Disease Drug Revenue by Country (2016-2027)
7.3 North America Alzheimer's Disease Drug Sales by Type
7.4 North America Alzheimer's Disease Drug Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Alzheimer's Disease Drug Market Size YoY Growth 2016-2027
8.2 Asia-Pacific Alzheimer's Disease Drug Market Facts & Figures by Region
8.2.1 Asia-Pacific Alzheimer's Disease Drug Sales by Region (2016-2027)
8.2.2 Asia-Pacific Alzheimer's Disease Drug Revenue by Region (2016-2027)
8.3 Asia-Pacific Alzheimer's Disease Drug Sales by Type
8.4 Asia-Pacific Alzheimer's Disease Drug Sales by Application
9 Europe
9.1 Europe Alzheimer's Disease Drug Market Size YoY Growth 2016-2027
9.2 Europe Alzheimer's Disease Drug Market Facts & Figures by Country
9.2.1 Europe Alzheimer's Disease Drug Sales by Country (2016-2027)
9.2.2 Europe Alzheimer's Disease Drug Revenue by Country (2016-2027)
9.3 Europe Alzheimer's Disease Drug Sales by Type
9.4 Europe Alzheimer's Disease Drug Sales by Application
10 Latin America
10.1 Latin America Alzheimer's Disease Drug Market Size YoY Growth 2016-2027
10.2 Latin America Alzheimer's Disease Drug Market Facts & Figures by Country
10.2.1 Latin America Alzheimer's Disease Drug Sales by Country (2016-2027)
10.2.2 Latin America Alzheimer's Disease Drug Revenue by Country (2016-2027)
10.3 Latin America Alzheimer's Disease Drug Sales by Type
10.4 Latin America Alzheimer's Disease Drug Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Alzheimer's Disease Drug Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Alzheimer's Disease Drug Market Facts & Figures by Country
11.2.1 Middle East and Africa Alzheimer's Disease Drug Sales by Country (2016-2027)
11.2.2 Middle East and Africa Alzheimer's Disease Drug Revenue by Country (2016-2027)
11.3 Middle East and Africa Alzheimer's Disease Drug Sales by Type
11.4 Middle East and Africa Alzheimer's Disease Drug Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Alzheimer's Disease Drug Supply Chain Analysis
12.2 Alzheimer's Disease Drug Key Raw Materials and Upstream Suppliers
12.3 Alzheimer's Disease Drug Clients Analysis
12.4 Alzheimer's Disease Drug Sales Channel and Sales Model Analysis
12.4.1 Alzheimer's Disease Drug Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Alzheimer's Disease Drug Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Alzheimer's Disease Drug Distributors
13 Market Dynamics
13.1 Alzheimer's Disease Drug Market Drivers
13.2 Alzheimer's Disease Drug Market Opportunities
13.3 Alzheimer's Disease Drug Market Challenges
13.4 Alzheimer's Disease Drug Market Restraints
13.5 Porter's Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Alzheimer's Disease Drug Market Size Growth Rate by Type (US$ Million): 2021 VS 2027
Table 2. Major Manufacturers of Donepezil
Table 3. Major Manufacturers of Memantine
Table 4. Major Manufacturers of Rivastigmine
Table 5. Major Manufacturers of Others
Table 6. Global Alzheimer's Disease Drug Market Size Growth by Application (US$ Million): 2021 VS 2027
Table 7. Global Alzheimer's Disease Drug Market Size by Region (US$ Million): 2021 VS 2027
Table 8. Global Alzheimer's Disease Drug Sales by Region (2016-2021) & (M Units)
Table 9. Global Alzheimer's Disease Drug Sales Forecast by Region (2022-2027) & (M Units)
Table 10. Global Alzheimer's Disease Drug Revenue by Region (2016-2021) & (US$ Million)
Table 11. Global Alzheimer's Disease Drug Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Alzheimer's Disease Drug Sales by Manufacturer (2016-2021) & (M Units)
Table 13. Global Alzheimer's Disease Drug Sales Share by Manufacturer (2016-2021)
Table 14. Alzheimer's Disease Drug Revenue by Manufacturer (2016-2021) & (US$ Million)
Table 15. Alzheimer's Disease Drug Revenue Share by Manufacturer (2016-2021)
Table 16. Key Manufacturers Alzheimer's Disease Drug Price (2016-2021) & (US$/Unit)
Table 17. Ranking of Global Top Alzheimer's Disease Drug Manufacturers by Revenue (US$ Million) in 2020
Table 18. Global Alzheimer's Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Alzheimer's Disease Drug by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Alzheimer's Disease Drug as of 2020)
Table 20. Alzheimer's Disease Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Alzheimer's Disease Drug Product Type
Table 22. Date of International Manufacturers Enter into Alzheimer's Disease Drug Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Allergan Corporation Information
Table 25. Allergan Description and Business Overview
Table 26. Allergan Alzheimer's Disease Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 27. Allergan Alzheimer's Disease Drug Product
Table 28. Allergan Alzheimer's Disease Drug Revenue (US$ Million) and Market Share by Product
Table 29. Allergan Alzheimer's Disease Drug Revenue (US$ Million) and Market Share by Application
Table 30. Allergan Alzheimer's Disease Drug Revenue (US$ Million) and Market Share by Geographic Area
Table 31. Allergan Alzheimer's Disease Drug Revenue (US$ Million) and Market Share by Sales Channel
Table 32. Allergan Recent Development
Table 33. Eisai Corporation Information
Table 34. Eisai Description and Business Overview
Table 35. Eisai Alzheimer's Disease Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 36. Eisai Alzheimer's Disease Drug Product
Table 37. Eisai Alzheimer's Disease Drug Revenue (US$ Million) and Market Share by Product
Table 38. Eisai Alzheimer's Disease Drug Revenue (US$ Million) and Market Share by Application
Table 39. Eisai Alzheimer's Disease Drug Revenue (US$ Million) and Market Share by Geographic Area
Table 40. Eisai Alzheimer's Disease Drug Revenue (US$ Million) and Market Share by Sales Channel
Table 41. Eisai Recent Development
Table 42. Novartis Corporation Information
Table 43. Novartis Description and Business Overview
Table 44. Novartis Alzheimer's Disease Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 45. Novartis Alzheimer's Disease Drug Product
Table 46. Novartis Alzheimer's Disease Drug Revenue (US$ Million) and Market Share by Product
Table 47. Novartis Alzheimer's Disease Drug Revenue (US$ Million) and Market Share by Application
Table 48. Novartis Alzheimer's Disease Drug Revenue (US$ Million) and Market Share by Geographic Area
Table 49. Novartis Alzheimer's Disease Drug Revenue (US$ Million) and Market Share by Sales Channel
Table 50. Novartis Recent Development
Table 51. Daiichi Sankyo Corporation Information
Table 52. Daiichi Sankyo Description and Business Overview
Table 53. Daiichi Sankyo Alzheimer's Disease Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 54. Daiichi Sankyo Alzheimer's Disease Drug Product
Table 55. Daiichi Sankyo Alzheimer's Disease Drug Revenue (US$ Million) and Market Share by Product
Table 56. Daiichi Sankyo Alzheimer's Disease Drug Revenue (US$ Million) and Market Share by Application
Table 57. Daiichi Sankyo Alzheimer's Disease Drug Revenue (US$ Million) and Market Share by Geographic Area
Table 58. Daiichi Sankyo Alzheimer's Disease Drug Revenue (US$ Million) and Market Share by Sales Channel
Table 59. Daiichi Sankyo Recent Development
Table 60. Merz Pharma Corporation Information
Table 61. Merz Pharma Description and Business Overview
Table 62. Merz Pharma Alzheimer's Disease Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 63. Merz Pharma Alzheimer's Disease Drug Product
Table 64. Merz Pharma Alzheimer's Disease Drug Revenue (US$ Million) and Market Share by Product
Table 65. Merz Pharma Alzheimer's Disease Drug Revenue (US$ Million) and Market Share by Application
Table 66. Merz Pharma Alzheimer's Disease Drug Revenue (US$ Million) and Market Share by Geographic Area
Table 67. Merz Pharma Alzheimer's Disease Drug Revenue (US$ Million) and Market Share by Sales Channel
Table 68. Merz Pharma Recent Development
Table 69. Pfizer Corporation Information
Table 70. Pfizer Description and Business Overview
Table 71. Pfizer Alzheimer's Disease Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 72. Pfizer Alzheimer's Disease Drug Product
Table 73. Pfizer Alzheimer's Disease Drug Revenue (US$ Million) and Market Share by Product
Table 74. Pfizer Alzheimer's Disease Drug Revenue (US$ Million) and Market Share by Application
Table 75. Pfizer Alzheimer's Disease Drug Revenue (US$ Million) and Market Share by Geographic Area
Table 76. Pfizer Recent Development
Table 77. Johnson & Johnson Corporation Information
Table 78. Johnson & Johnson Description and Business Overview
Table 79. Johnson & Johnson Alzheimer's Disease Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 80. Johnson & Johnson Alzheimer's Disease Drug Product
Table 81. Johnson & Johnson Alzheimer's Disease Drug Revenue (US$ Million) and Market Share by Product
Table 82. Johnson & Johnson Alzheimer's Disease Drug Revenue (US$ Million) and Market Share by Application
Table 83. Johnson & Johnson Alzheimer's Disease Drug Revenue (US$ Million) and Market Share by Geographic Area
Table 84. Johnson & Johnson Recent Development
Table 85. Lundbeck Corporation Information
Table 86. Lundbeck Description and Business Overview
Table 87. Lundbeck Alzheimer's Disease Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 88. Lundbeck Alzheimer's Disease Drug Product
Table 89. Lundbeck Alzheimer's Disease Drug Revenue (US$ Million) and Market Share by Product
Table 90. Lundbeck Alzheimer's Disease Drug Revenue (US$ Million) and Market Share by Application
Table 91. Lundbeck Alzheimer's Disease Drug Revenue (US$ Million) and Market Share by Geographic Area
Table 92. Lundbeck Recent Development
Table 93. Global Alzheimer's Disease Drug Sales by Type (2016-2021) & (M Units)
Table 94. Global Alzheimer's Disease Drug Sales Forecast by Type (2022-2027) & (M Units)
Table 95. Global Alzheimer's Disease Drug Revenue by Type (2016-2021) & (US$ Million)
Table 96. Global Alzheimer's Disease Drug Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 97. Global Alzheimer's Disease Drug Sales by Application (2016-2021) & (M Units)
Table 98. Global Alzheimer's Disease Drug Sales Forecast by Application (2022-2027) & (M Units)
Table 99. Global Alzheimer's Disease Drug Revenue by Application (2016-2021) & (US$ Million)
Table 100. Global Alzheimer's Disease Drug Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 101. North America Alzheimer's Disease Drug Sales by Country (2016-2021) & (M Units)
Table 102. North America Alzheimer's Disease Drug Sales by Country (2022-2027) & (M Units)
Table 103. North America Alzheimer's Disease Drug Revenue by Country (2016-2021) & (US$ Million)
Table 104. North America Alzheimer's Disease Drug Revenue by Country (2022-2027) & (US$ Million)
Table 105. North America Alzheimer's Disease Drug Sales by Type (2016-2021) & (M Units)
Table 106. North America Alzheimer's Disease Drug Sales by Application (2016-2021) & (M Units)
Table 107. Asia-Pacific Alzheimer's Disease Drug Sales by Region (2016-2021) & (M Units)
Table 108. Asia-Pacific Alzheimer's Disease Drug Sales by Region (2022-2027) & (M Units)
Table 109. Asia-Pacific Alzheimer's Disease Drug Revenue by Region (2016-2027) & (US$ Million)
Table 110. Asia-Pacific Alzheimer's Disease Drug Revenue by Region (2022-2027) & (US$ Million)
Table 111. Asia-Pacific Alzheimer's Disease Drug Sales by Type (2016-2021) & (M Units)
Table 112. Asia-Pacific Alzheimer's Disease Drug Sales by Application (2016-2021) & (M Units)
Table 113. Europe Alzheimer's Disease Drug Sales by Country (2016-2021) & (M Units)
Table 114. Europe Alzheimer's Disease Drug Sales by Country (2022-2027) & (M Units)
Table 115. Europe Alzheimer's Disease Drug Revenue by Country (2016-2021) & (US$ Million)
Table 116. Europe Alzheimer's Disease Drug Revenue by Country (2022-2027) & (US$ Million)
Table 117. Europe Alzheimer's Disease Drug Sales by Type (2016-2021) & (M Units)
Table 118. Europe Alzheimer's Disease Drug Sales by Application (2016-2021) & (M Units)
Table 119. Latin America Alzheimer's Disease Drug Sales by Country (2016-2021) & (M Units)
Table 120. Latin America Alzheimer's Disease Drug Sales by Country (2022-2027) & (M Units)
Table 121. Latin America Alzheimer's Disease Drug Revenue by Country (2016-2021) & (US$ Million)
Table 122. Latin America Alzheimer's Disease Drug Revenue by Country (2022-2027) & (US$ Million)
Table 123. Latin America Alzheimer's Disease Drug Sales by Type (2016-2021) & (M Units)
Table 124. Latin America Alzheimer's Disease Drug Sales by Application (2016-2021) & (M Units)
Table 125. Middle East and Africa Alzheimer's Disease Drug Sales by Country (2016-2021) & (M Units)
Table 126. Middle East and Africa Alzheimer's Disease Drug Sales by Country (2022-2027) & (M Units)
Table 127. Middle East and Africa Alzheimer's Disease Drug Revenue by Country (2016-2021) & (US$ Million)
Table 128. Middle East and Africa Alzheimer's Disease Drug Revenue by Country (2022-2027) & (US$ Million)
Table 129. Middle East and Africa Alzheimer's Disease Drug Sales by Type (2016-2021) & (M Units)
Table 130. Middle East and Africa Alzheimer's Disease Drug Sales by Application (2016-2021) & (M Units)
Table 131. Alzheimer's Disease Drug Key Raw Materials, Industry Status and Trend
Table 132. Alzheimer's Disease Drug Key Raw Materials and Upstream Suppliers
Table 133. Alzheimer's Disease Drug Clients Status and Trend
Table 134. Alzheimer's Disease Drug Typical Clients
Table 135. Alzheimer's Disease Drug Distributors
Table 136. Key Drivers: Impact Analysis (2022-2027)
Table 137. Alzheimer's Disease Drug Market Drivers
Table 138. Alzheimer's Disease Drug Market Opportunities
Table 139. Alzheimer's Disease Drug Market Challenges
Table 140. Alzheimer's Disease Drug Market Restraints
Table 141. Alzheimer's Disease Drug Porter's Five Forces Analysis
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Alzheimer's Disease Drug Product Picture
Figure 2. Global Alzheimer's Disease Drug Sales Market Share by Type in 2021 & 2027
Figure 3. Donepezil Product Picture
Figure 4. Memantine Product Picture
Figure 5. Rivastigmine Product Picture
Figure 6. Others Product Picture
Figure 7. Global Alzheimer's Disease Drug Sales Market Share by Application in 2021 & 2027
Figure 8. Early to Moderate Stages Examples
Figure 9. Moderate to Severe Stages Examples
Figure 10. Alzheimer's Disease Drug Report Years Considered
Figure 11. Global Alzheimer's Disease Drug Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Alzheimer's Disease Drug Market Size 2016-2027 (US$ Million)
Figure 13. Global Alzheimer's Disease Drug Sales 2016-2027 (K Units)
Figure 14. Global Alzheimer's Disease Drug Market Size Market Share by Region: 2021 Versus 2027
Figure 15. Global Alzheimer's Disease Drug Sales Market Share Forecast by Region (2016-2027)
Figure 16. Global Alzheimer's Disease Drug Revenue Market Share by Region (2016-2027)
Figure 17. Global Alzheimer's Disease Drug Sales Share by Manufacturer in 2020
Figure 18. Alzheimer's Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 19. Global Alzheimer's Disease Drug Sales Market Share Forecast by Type (2016-2027)
Figure 20. Global Alzheimer's Disease Drug Revenue Market Share Forecast by Type (2016-2027)
Figure 21. Alzheimer's Disease Drug Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Figure 22. Global Alzheimer's Disease Drug Sales Market Share Forecast by Application (2016-2027)
Figure 23. Global Alzheimer's Disease Drug Revenue Market Share Forecast by Application (2016-2027)
Figure 24. Alzheimer's Disease Drug Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Figure 25. North America Alzheimer's Disease Drug Revenue 2016-2027 (US$ Million)
Figure 26. North America Alzheimer's Disease Drug Sales Market Share by Type (2016-2021)
Figure 27. North America Alzheimer's Disease Drug Sales Market Share by Application (2016-2021)
Figure 28. Asia-Pacific Alzheimer's Disease Drug Revenue 2016-2027 (US$ Million)
Figure 29. Asia-Pacific Alzheimer's Disease Drug Sales Market Share by Region (2016-2027)
Figure 30. Asia-Pacific Alzheimer's Disease Drug Revenue Market Share by Region (2016-2027)
Figure 31. Asia-Pacific Alzheimer's Disease Drug Sales Market Share by Type (2016-2021)
Figure 32. Asia-Pacific Alzheimer's Disease Drug Sales Market Share by Application (2016-2021)
Figure 33. Europe Alzheimer's Disease Drug Revenue Growth Rate 2016-2027 (US$ Million)
Figure 34. Europe Alzheimer's Disease Drug Sales Market Share by Country (2016-2027)
Figure 35. Europe Alzheimer's Disease Drug Revenue Market Share by Country (2016-2027)
Figure 36. Europe Alzheimer's Disease Drug Sales Market Share by Type (2016-2021)
Figure 37. Europe Alzheimer's Disease Drug Sales Market Share by Application (2016-2021)
Figure 38. Latin America Alzheimer's Disease Drug Revenue Growth Rate 2016-2027 (US$ Million)
Figure 39. Latin America Alzheimer's Disease Drug Sales Market Share by Country (2016-2027)
Figure 40. Latin America Alzheimer's Disease Drug Revenue Market Share by Country (2016-2021)
Figure 41. Latin America Alzheimer's Disease Drug Sales Market Share by Type (2016-2021)
Figure 42. Latin America Alzheimer's Disease Drug Sales Market Share by Application (2016-2021)
Figure 43. Middle East and Africa Alzheimer's Disease Drug Revenue Growth Rate 2016-2027 (US$ Million)
Figure 44. Middle East and Africa Alzheimer's Disease Drug Sales Market Share by Country (2016-2027)
Figure 45. Middle East and Africa Alzheimer's Disease Drug Revenue Market Share by Country (2016-2027)
Figure 46. Middle East and Africa Alzheimer's Disease Drug Sales Market Share by Type (2016-2021)
Figure 47. Middle East and Africa Alzheimer's Disease Drug Sales Market Share by Application (2016-2021)
Figure 48. Alzheimer's Disease Drug Supply Chain (Upstream and Downstream Market)
Figure 49. Global Production Market Share of Alzheimer's Disease Drug Raw Materials by Region in 2020
Figure 50. Alzheimer's Disease Drug Distribution Channels
Figure 51. Global Alzheimer's Disease Drug Percentage 2016-2027: Indirect Sales VS Direct Sales
Figure 52. Global Alzheimer's Disease Drug Percentage 2016-2027: Online Sales VS Offline Sales
Figure 53. Porter's Five Forces Analysis
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
  • Global Alzheimer's Disease Drug Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027
    Published: 19-Jul-2021        Price: US 5900 Onwards        Pages: 118
    Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia. The major players in global Alzheimer's Disease Drug market include Allergan, Eisai, Novartis, Daiichi Sankyo, Merz Pharma, Pfizer, Johnson & Johnson, Lundbeck, etc. The top 3 players hold over 60% of global shares. Europe and North America are main markets, they occupy over 70% of the......
  • Global Alzheimer's Disease Drug Market Growth 2021-2026
    Published: 15-Jul-2021        Price: US 3660 Onwards        Pages: 91
    According to this latest study, the 2021 growth of Alzheimer's Disease Drug will have significant change from previous year. By the most conservative estimates of global Alzheimer's Disease Drug market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 3462 million in 2020. Over the next five years the Alzheimer's Disease Drug market will register a 1.6% CAGR in terms of revenue, the global market size will reach US$ 3682.6 million by 2026. ......
  • Global Dementia and Movement Disorder Treatment Market Size, Status and Forecast 2021-2027
    Published: 12-Jul-2021        Price: US 3900 Onwards        Pages: 105
    Dementia is a collective term for disorders characterized by progressive degeneration of the brain. It impairs memory and affects behavioral, emotional, and cognitive abilities. The neuronal death or neuronal malfunction associated with the disorder manifests as shifts in mood and personality changes, difficulty in performing activities, loss of memory, and aphasia. The treatment for dementia is conducted through therapeutic approaches that provide symptomatic relief as the drugs intended......
  • Global Oxiracetam Sales Market Report 2021
    Published: 21-Jun-2021        Price: US 4000 Onwards        Pages: 137
    The global Oxiracetam market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Oxiracetam market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Injection - Capsule Segment by Applicati......
  • 2020-2025 Global Alzheimer's Disease Drug Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)
    Published: 01-Jun-2021        Price: US 3360 Onwards        Pages: 96
    Alzheimer's disease is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia. This report elaborates the market size, market characteristics, and market growth of the Alzheimer's Disease Drug industry, and breaks down according to the type, application, and consumption area of Alzheimer's Disease Drug. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entr......
  • Global Alzheimer's Disease Drug Market Insights and Forecast to 2027
    Published: 26-May-2021        Price: US 4900 Onwards        Pages: 111
    Alzheimer's Disease Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Alzheimer's Disease Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027. Segment by Type - Donepezil - Memantine - Rivastigmine Segment by Application ......
  • Global Alzheimer's Drugs Sales Market Report 2021
    Published: 13-Apr-2021        Price: US 4000 Onwards        Pages: 116
    The global Alzheimer's Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Alzheimer's Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Acetylcholinesterase (AChE) Inhibitors - ......
  • Global Oxiracetam Market Growth 2021-2026
    Published: 08-Apr-2021        Price: US 3660 Onwards        Pages: 137
    According to this latest study, the 2021 growth of Oxiracetam will have significant change from previous year. By the most conservative estimates of global Oxiracetam market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Oxiracetam market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overvi......
  • Global Alzheimer's Disease Drug Sales Market Report 2021
    Published: 31-Mar-2021        Price: US 4000 Onwards        Pages: 131
    The global Alzheimer's Disease Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Alzheimer's Disease Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Donepezil - Memantine......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs